We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Estee Lauder (EL) to Post Q2 Earnings: What's in Store?
Read MoreHide Full Article
The Estee Lauder Companies Inc. (EL - Free Report) is likely to post a decline in the top and the bottom line when it reports second-quarter fiscal 2021 numbers on Feb 5. Though the Zacks Consensus Estimate for fiscal second-quarter earnings has moved up by a cent in the past seven days to $1.66 per share, it suggests a 21.3% slump from the year-ago quarter’s reported figure. We note that this cosmetics giant has a trailing four-quarter negative earnings surprise of 22.6%, on average.
The consensus estimate for quarterly revenues is pegged at $4.48 billion, which suggests a decline of 3.1% from the prior-year quarter’s tally.
The Estee Lauder Companies Inc. Price and EPS Surprise
Estee Lauder is bearing the brunt of coronavirus-induced hurdles like soft store traffic. Management, in its last earnings call, highlighted that restrictions on travel due to government orders and consumer health concerns amid COVID-19 has been hurting consumer traffic in most travel retail locations. As part of its two-year Post-COVID Business Acceleration Program introduced in August 2020, the company had unveiled plans to reduce retail footprint. Through this plan, management expected shutting 10-15% of its freestanding stores worldwide along with various low-performing department store counters. Also, the company mentioned that various retailers decided to undertake planned reduction of their footprint via door closures amid the pandemic.
For the fiscal second quarter, Estee Lauder projects revenue decline in the band of 5-3% that includes a contribution of nearly 2% from Dr. Jart+ acquisition and a positive currency impact of 1%. Excluding these, management expects net sales decrease of 8-6% in the quarter under review. Further, adjusted earnings are anticipated between $1.45 and $1.60 per share in the fiscal second quarter. Excluding share dilution related to the acquisition, management expects 31-24% decline in adjusted earnings per share at constant currency.
Nevertheless, Estee Lauder has been undertaking several actions to curb expenses amid the crisis. These include costs related to advertising and promotion activities, travel, meetings, consulting and certain employee expenses. Apart from these, the company’s focus on augmenting its e-commerce business as well as strength in the Skin Care portfolio bodes well.
What the Zacks Model Unveils
Our proven model predicts an earnings beat for Estee Lauder this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Estee Lauder carries a Zacks Rank #3 and an Earnings ESP of +1.00%.
More Stocks With Favorable Combinations
Here are some more companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat.
The Clorox Company (CLX - Free Report) currently has an Earnings ESP of +0.30% and a Zacks Rank of 3.
Kellogg Company (K - Free Report) currently has an Earnings ESP of +0.15% and carries a Zacks Rank #3.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early. See the 5 high-tech stocks now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Estee Lauder (EL) to Post Q2 Earnings: What's in Store?
The Estee Lauder Companies Inc. (EL - Free Report) is likely to post a decline in the top and the bottom line when it reports second-quarter fiscal 2021 numbers on Feb 5. Though the Zacks Consensus Estimate for fiscal second-quarter earnings has moved up by a cent in the past seven days to $1.66 per share, it suggests a 21.3% slump from the year-ago quarter’s reported figure. We note that this cosmetics giant has a trailing four-quarter negative earnings surprise of 22.6%, on average.
The consensus estimate for quarterly revenues is pegged at $4.48 billion, which suggests a decline of 3.1% from the prior-year quarter’s tally.
The Estee Lauder Companies Inc. Price and EPS Surprise
The Estee Lauder Companies Inc. price-eps-surprise | The Estee Lauder Companies Inc. Quote
Factors to Note
Estee Lauder is bearing the brunt of coronavirus-induced hurdles like soft store traffic. Management, in its last earnings call, highlighted that restrictions on travel due to government orders and consumer health concerns amid COVID-19 has been hurting consumer traffic in most travel retail locations. As part of its two-year Post-COVID Business Acceleration Program introduced in August 2020, the company had unveiled plans to reduce retail footprint. Through this plan, management expected shutting 10-15% of its freestanding stores worldwide along with various low-performing department store counters. Also, the company mentioned that various retailers decided to undertake planned reduction of their footprint via door closures amid the pandemic.
For the fiscal second quarter, Estee Lauder projects revenue decline in the band of 5-3% that includes a contribution of nearly 2% from Dr. Jart+ acquisition and a positive currency impact of 1%. Excluding these, management expects net sales decrease of 8-6% in the quarter under review. Further, adjusted earnings are anticipated between $1.45 and $1.60 per share in the fiscal second quarter. Excluding share dilution related to the acquisition, management expects 31-24% decline in adjusted earnings per share at constant currency.
Nevertheless, Estee Lauder has been undertaking several actions to curb expenses amid the crisis. These include costs related to advertising and promotion activities, travel, meetings, consulting and certain employee expenses. Apart from these, the company’s focus on augmenting its e-commerce business as well as strength in the Skin Care portfolio bodes well.
What the Zacks Model Unveils
Our proven model predicts an earnings beat for Estee Lauder this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Estee Lauder carries a Zacks Rank #3 and an Earnings ESP of +1.00%.
More Stocks With Favorable Combinations
Here are some more companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat.
The Hershey Company (HSY - Free Report) currently has an Earnings ESP of +1.79% and carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Clorox Company (CLX - Free Report) currently has an Earnings ESP of +0.30% and a Zacks Rank of 3.
Kellogg Company (K - Free Report) currently has an Earnings ESP of +0.15% and carries a Zacks Rank #3.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
See the 5 high-tech stocks now>>